bioRxivDevelopmental BiologyPreprint
Establishment of Tuberculosis Meningitis Mouse Model Using Aerosol Route of W. Beijing HN878 strain
Bhagwati L. KhatriiD, Sara Goulding, Vicky Rannow, Belinda M. Dagg, Mei Mei Ho
Abstract
In this study, we report the development of a tuberculosis meningitis (TBM) mouse model using the HN878 strain via the aerosol route. Three genetically different strains of mice, CB6F1, C57BL/6 and BALB/c mice, were used to determine the dissemination of HN878 in the brain. The 8 x 108 CFU/ml of HN878 dose was used to infect CB6F1 mice and deposited approximately 3.8 (0.07, SD) log10 CFU in the lungs. The burden of HN878 in the brain of the control group (administered saline) after approximately 16/17 days post-infection for CB6F1, C57BL/6 and BALB/c were 4.00 (0.47 SD), 3.79 (0.27, SD) and 2.12 (0.41, SD) log10 CFU/brain, respectively. The log10 CFU/brain in the BCG vaccinated CB6F1, C57BL/6 and BALB/c mice were 1.05 (0.61, SD), 2.13 (0.33, SD) and 1.42 (0.38, SD) respectively, which, if compared to the control groups, BCG vaccinated mice inhibited dissemination of HN878 in the brain by an impressive 2.94 (CB6F1), 1.66 (C57BL/6) and 0.69 (BALB/c) log10 CFU/brain reduction. In conclusion, we have established a relatively inexpensive TBM mouse model using an aerosol, a natural route of infection, which will advance research in understanding TBM dissemination to the brain, and preclinical tuberculosis vaccine/drug discovery/drug regimens against TBM.
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Efficacy and immunogenicity of different BCG doses in BALB/c and CB6F1 mice when challenged with H37Rv or Beijing HN878
- BCG vaccination reduces the rate of Mycobacterium tuberculosis dissemination between murine lungs
Dipanjan Chakraborty, Vitaly V. Ganusov·bioRxiv·Aug 25, 2026
- Nos2-/- mice infected with M. tuberculosis develop neurobehavioral changes and immunopathology mimicking human central nervous system tuberculosis
X. Y. Poh, J. M. Hong, … C. W. M. Ong·bioRxiv·Aug 15, 2021
- Attenuated Mycobacterium tuberculosis Vaccine Protection in a Low Dose Murine Challenge Model
S. J. Vidal, D. Sellers, … D. H. Barouch·bioRxiv·Mar 17, 2023
- Mouse Models Uniformly Featuring Human-like Lesions Harboring Drug-tolerant Mycobacterium tuberculosis
Gaëlle Guiewi Makafe, Timothy C. Low-Beer, … Brian C. Weinrick·bioRxiv·Oct 17, 2025
- Improved Immune Responses and Tuberculosis Protection by Aerosol Vaccination with recombinant BCG expressing ESX-1 from Mycobacterium marinum
Fadel Sayes, Wafa Frigui, … Roland Brosch·PLoS PathogensPeer-reviewed·Feb 23, 2026